Jens Brange

6.0k total citations · 2 hit papers
53 papers, 5.0k citations indexed

About

Jens Brange is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Jens Brange has authored 53 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Jens Brange's work include Diabetes Management and Research (14 papers), Metabolism, Diabetes, and Cancer (13 papers) and Pancreatic function and diabetes (12 papers). Jens Brange is often cited by papers focused on Diabetes Management and Research (14 papers), Metabolism, Diabetes, and Cancer (13 papers) and Pancreatic function and diabetes (12 papers). Jens Brange collaborates with scholars based in Denmark, United Kingdom and United States. Jens Brange's co-authors include Sven Frøkjær, Aage Vølund, Vladimir N. Uversky, Anthony L. Fink, Svend Havelund, R. Khurana, Sandip B. Vyas, David R. Owens, Steven Kang and Lennart Andersen and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Jens Brange

53 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Environmental Factors on the Kinetics of Insulin Fibril Formation: Elucidation of the Molecular Mechanism

2001 1.0k citations Sven Frøkjær, Jens Brange et al. profile →
Monomeric insulins obtained by protein engineering and their medical implications

1988 397 citations Jens Brange, Ulla Ribel et al. profile →

Peers

Countries citing papers authored by Jens Brange

Since Specialization

Citations

This map shows the geographic impact of Jens Brange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Brange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Brange more than expected).

Fields of papers citing papers by Jens Brange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Brange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Brange. The network helps show where Jens Brange may publish in the future.

Co-authorship network of co-authors of Jens Brange

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Brange. A scholar is included among the top collaborators of Jens Brange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Brange. Jens Brange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prediction of the association state of insulin using spectral parameters 2003 ·Journal of Pharmaceutical Sciences ·Vladimir N. Uversky, (unknown), Ian S. Millett, Sven Frøkjær, Jens Brange, Sebastian Doniach, Anthony L. Fink	72
2	Insulin Formulation and Delivery 2002 ·Pharmaceutical biotechnology ·Jens Brange, Lotte Langkjær	36
3	The Effect of Mutations on the Structure of Insulin Fibrils Studied by Fourier Transform Infrared (FTIR) Spectroscopy and Electron Microscopy 2002 ·Journal of Pharmaceutical Sciences ·(unknown), Sven Frøkjær, John F. Carpenter, Jens Brange	20
4	Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization 2001 ·Glycobiology ·Thomas Østerbye, (unknown), Pam Fredman, J Tranum-Jensen, Anne Kaas, Jens Brange, Jean L. Whittingham, Karsten Buschard	41
5	Crystallization and preliminary crystallographic investigation of a low-pH native insulin monomer with flexible behaviour 2001 ·Acta Crystallographica Section D Biological Crystallography ·(unknown), Jean L. Whittingham, J.P. Turkenburg, E.J. Dodson, Jens Brange, G.G. Dodson	17
6	Studies of the Structure of Insulin Fibrils by Fourier Transform Infrared (FTIR) Spectroscopy and Electron Microscopy 2001 ·Journal of Pharmaceutical Sciences ·(unknown), Sven Frøkjær, John F. Carpenter, Jens Brange	173
7	Insulin structure and diabetes treatment 1997 ·RWTH Publications (RWTH Aachen) ·Jens Brange, (unknown), Dorothy Farrar Edwards, (unknown), Axel Wollmer, (unknown), G.G. Dodson, (unknown)	6
8	The new era of biotech insulin analogues 1997 ·Diabetologia ·Jens Brange	58
9	Toward Understanding Insulin Fibrillation 1997 ·Journal of Pharmaceutical Sciences ·Jens Brange, Lennart Andersen, (unknown), (unknown), (unknown)	438
10	Stability of insulin : studies on the physical and chemical stability of insulin in pharmaceutical formulation 1994 ·Kluwer Academic Publishers eBooks ·Jens Brange	35
11	Insulin assembly: its modification by protein engineering and ligand binding 1993 ·Philosophical Transactions of the Royal Society of London Series A Physical and Engineering Sciences ·E.J. Dodson, G.G. Dodson, R.E. Hubbard, P.C.E. Moody, J.P. Turkenburg, Jean L. Whittingham, Bing Xiao, Jens Brange, Niels C. Kaarsholm, Henning Thøgersen	6
12	Chemical Stability of Insulin. 2. Formation of Higher Molecular Weight Transformation Products During Storage of Pharmaceutical Preparations 1992 ·Pharmaceutical Research ·Jens Brange, Svend Havelund, Philip Hougaard	108
13	Role of B13 Glu in insulin assembly 1992 ·Journal of Molecular Biology ·G.A. Bentley, Jens Brange, Zygmunt S. Derewenda, E.J. Dodson, Guy Dodson, Jan Markussen, Anthony J. Wilkinson, Axel Wollmer, Bo Xiao	38
14	Chemical Stability of Insulin. 1. Hydrolytic Degradation During Storage of Pharmaceutical Preparations 1992 ·Pharmaceutical Research ·Jens Brange, (unknown), Svend Havelund, Aage Vølund	118
15	In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use 1991 ·Diabetic Medicine ·Aa. Vølund, Jens Brange, Kirsten Drejer, I. Jensen, J. Markussen, Ulla Ribel, A.R. Sørensen, (unknown)	60
16	Sequence-specific 1H-NMR assignments for the aromatic region of several biologically active, monomeric insulins including native human insulin 1990 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), (unknown), Niels C. Kaarsholm, Henning Thøgersen, Jens Brange, Michael F. Dunn	13
17	Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes 1990 ·The Lancet ·Seungha Kang, David R. Owens, J Vora, Jens Brange	23
18	Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects. 1988 ·BMJ ·Jiten Vora, David R. Owens, J. Dolben, (unknown), (unknown), Seungha Kang, (unknown), Jens Brange	29
19	Fast atom bombardment and plasma desorption mass spectrometry of degraded insulins in intermediate and long‐acting preparations 1988 ·Rapid Communications in Mass Spectrometry ·S. E. Unger, Jens Brange, Anna Lauritano, Plamen A. Demirev, (unknown), Robert J. Cotter, R. Graham Cooks	2
20	Insulin Compatibility with Polymer Materials Used in External Pump Infusion Systems 1988 ·Diabetic Medicine ·Steen Melberg, Svend Havelund, John Villumsen, Jens Brange	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact